Articles related to NAUSEA & VOMITING

GLP-1 Weight Loss Can Come with a Rare—But Serious—Neurologic Complication

A review identified 15 reports of Wernicke encephalopathy among patients receiving GLP-1 therapies, most accompanied by poor intake, vomiting, weight loss, or malnutrition, highlighting a rare safety signal without establishing drug-related causality.

Emergency Medicine October 22nd 2026

Tags: ADVERSE EVENTS DIET & NUTRITION DRUG SAFETY & INTERACTIONS GLP-1 RECEPTOR AGONISTS NAUSEA & VOMITING OBESITY/WEIGHT MANAGEMENT PHARMACOVIGILANCE RARE CONDITIONS & DISEASES VITAMINS/SUPPLEMENTS

Clinical Advisor

Clinical Challenge: Vomiting and Weakness

Because the patient was complaining of both chest discomfort and dyspnea–which can be caused by vomiting and dehydration–the clinician must consider a potential coronary etiology, even in a 38-year-old.

Cardiology March 27th 2026

Tags: ANTIEMETICS CLINICAL CHALLENGE DRUG SAFETY & INTERACTIONS ELECTROLYTES HYPOKALEMIA IMAGING/SCREENING NAUSEA & VOMITING

MDLinx

An Unpleasant Syndrome Surfaces as Cannabis Use Grows

High-potency cannabis use has emerged as a significant factor in cyclic vomiting presentations, requiring clinicians to carefully evaluate usage patterns and consider CHS in their differential diagnosis.

Emergency Medicine October 28th 2024

Tags: ADDICTION MEDICINE CANNABIS USE DISORDERS CANNABIS/MARIJUANA DRUG SAFETY & INTERACTIONS NAUSEA & VOMITING PATIENT EDUCATION

Anesthesiology News

Dopamine-antagonist Antiemetics in PONV Management: Entering a New Era?

The evolving use of dopamine D2-receptor antagonists, marked by safety concerns and an FDA black box warning on droperidol, has seen a resurgence with the FDA-approved amisulpride, highlighting the need for further research to explore its comparison with other antiemetics and its role in multimodal PONV management.

Anesthesiology July 20th 2023

Tags: ANTIEMETICS NAUSEA & VOMITING

Trending Topics:

Articles related to NAUSEA & VOMITING

GLP-1 Weight Loss Can Come with a Rare—But Serious—Neurologic Complication

Clinical Challenge: Vomiting and Weakness

An Unpleasant Syndrome Surfaces as Cannabis Use Grows

Dopamine-antagonist Antiemetics in PONV Management: Entering a New Era?

Topics

Sources

The Healthcare Communications Network is owned and operated by IQVIA Inc. Click below to leave this site and continue to IQVIA’s Privacy Choices form

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form